首页> 外国专利> CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.

CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.

机译:Psilocybe推导剂的控制释放制剂及其使用方法,以及用于威胁性创伤性脑损伤的方法和组合物与后创伤后应激障碍。

摘要

The current application relates to a controlled release formulation of psilocybe-derived agent, wherein psilocybe-derived agent is formulated in multiple layers to release the agent at multiple different times, locations, and dosages during dosing. The formulation is used for treating mild traumatic brain injury (mTBI) with post traumatic stress disorder (PTSD). The formulation can also be used in combination with a cannabis-derived agent.
机译:目前的应用涉及Psilocybe衍生剂的受控释放制剂,其中Psilocybe衍生的剂在多层中配制,以在给药期间在多个不同时间,位置和剂量下释放试剂。该配方用于治疗温和创伤性脑损伤(MTBI),具有创伤后应激障碍(PTSD)。制剂还可以与大麻衍生剂组合使用。

著录项

  • 公开/公告号WO2021072530A1

    专利类型

  • 公开/公告日2021-04-22

    原文格式PDF

  • 申请/专利权人 TASSILI LIFE SCIENCES CORP.;

    申请/专利号WO2020CA51371

  • 发明设计人 PIONTKOWSKI SHLOMO;

    申请日2020-10-14

  • 分类号A61K31/675;A61K9;A61P25;C07F9/572;

  • 国家 CA

  • 入库时间 2022-08-24 18:22:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号